Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Clinical trial NCT00032110 · COMPLETED

Trial details

NCT number: NCT00032110
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer

Start date: 2002-01-01
Primary completion: 2007-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.